Notch Therapeutics

NotchTX is a platform technology that uses stem cells to produce progenitor T-cells that can be manufactured at scale, will potentially be less toxic, longer lasting, and will substitute mature T-cells as a starting cell source for current and future T-cell therapies. ProT Therapeutics’ technology includes proprietary, fully-defined, scalable, serum-free and feeder-free method to generate proT cells from stem cells with high yield and purity.